CARGO Therapeutics (NASDAQ:CRGX – Get Free Report) was downgraded by stock analysts at Chardan Capital from a “buy” rating to ...

CARGO Therapeutics (NASDAQ:CRGX – Get Free Report) was downgraded by stock analysts at HC Wainwright from a “buy” rating to a “neutral” rating in a research report issued to clients and investors on ...

Fintel reports that on January 30, 2025, Chardan Capital downgraded their outlook for CARGO Therapeutics (NasdaqGS:CRGX) from ...

Chardan downgraded Cargo Therapeutics (CRGX) to Neutral from Buy without a price target The company will be discontinuing the Phase II FIRCE-1 ...

CARGO Therapeutics, Inc. (CRGX – Research Report) received a Hold rating and price target from Chardan Capital analyst Geulah Livshits ...

On Friday, Chardan Capital Markets began coverage of Unity Biotechnology Inc (NASDAQ:UBX) shares with a Buy rating and a $6.00 price target, representing significant upside from the current price of ...

Along with the evaluation of strategic alternatives, Eyenovia continues to progress development of its advanced Optejet device and is exploring options for use as both a consumer “user-filled” product ...

With assistance from Chardan, the Company will continue to assess a full range of strategic alternatives, including but not limited to, a business combination, sale of the Company, reverse merger ...

Fintel reports that on December 11, 2024, Chardan Capital downgraded their outlook for CervoMed (NasdaqCM:CRVO) from Buy to Neutral. Analyst Price Forecast Suggests 2,434.26% Upside As of December ...